Recent insider trading activity from Lindmark Bertil, including buys and sells reported to the SEC.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 4, 2023 | Damora Therapeutics, Inc. | $DMRA | Lindmark Bertil | Chief Medical Officer | A | Stock Option (right to buy) | 115000 | $0.00 | 115,000.0000 | 0 | 9999.99% | 0.00% |